Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Yodoshi T. Navigating liver transplantation after malabsorptive bariatric surgery: A new risk of rejection. World J Transplant 2026; 16(2): 114837 [PMID: 42281882 DOI: 10.5500/wjt.v16.i2.114837]
World J Transplant. Jun 18, 2026; 16(2): 114837 Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.114837
Navigating liver transplantation after malabsorptive bariatric surgery: A new risk of rejection
Toshifumi Yodoshi
Toshifumi Yodoshi, Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, United States
Author contributions: Yodoshi T contributed to the concept, design, manuscript writing, and editing, as well as the review of the literature.
Conflict-of-interest statement: The author declares that he has no conflict of interest to disclose.
Corresponding author: Toshifumi Yodoshi, MD, PhD, Advanced Nutrition Fellow, Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, Cincinnati, OH 45229, United States. toshifumi.yodoshi@cchmc.org
Received: September 29, 2025 Revised: December 4, 2025 Accepted: January 7, 2026 Published online: June 18, 2026 Processing time: 242 Days and 7.3 Hours
Core Tip
Core Tip: Malabsorptive bariatric surgery (for example, Roux-en-Y gastric bypass and duodenal switch) is increasingly common among liver transplant candidates. Chang et al report significantly higher rates, frequency, and earlier onset of biopsy-proven acute cellular rejection in recipients with prior malabsorptive anatomy, despite comparable perioperative outcomes and one-year survival. This editorial explores plausible mechanisms-especially impaired absorption of oral immunosuppressants-and outlines pragmatic strategies: Intensified therapeutic drug monitoring, dose and formulation adjustments (including extended-release tacrolimus), and multidisciplinary nutrition-pharmacy support to reduce rejection and protect long-term graft function.